[1]
Standardization of Uveitis Nomenclature (SUN) Working Group, Classification Criteria for Sympathetic Ophthalmia. American journal of ophthalmology. 2021 Aug;
[PubMed PMID: 33845005]
[2]
Zaharia MA,Lamarche J,Laurin M, Sympathetic uveitis 66 years after injury. Canadian journal of ophthalmology. Journal canadien d
[PubMed PMID: 6478310]
[3]
Albert DM,Diaz-Rohena R, A historical review of sympathetic ophthalmia and its epidemiology. Survey of ophthalmology. 1989 Jul-Aug;
[PubMed PMID: 2678549]
Level 3 (low-level) evidence
[4]
Kilmartin DJ,Dick AD,Forrester JV, Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. The British journal of ophthalmology. 2000 Mar;
[PubMed PMID: 10684834]
[6]
Brour J,Desjardins L,Lehoang P,Bodaghi B,Lumbroso-Lerouic L,Dendale R,Cassoux N, Sympathetic ophthalmia after proton beam irradiation for choroïdal melanoma. Ocular immunology and inflammation. 2012 Aug;
[PubMed PMID: 22646709]
[7]
Albahlal A,Al Dhibi H,Al Shahwan S,Khandekar R,Edward DP, Sympathetic ophthalmia following diode laser cyclophotocoagulation. The British journal of ophthalmology. 2014 Aug;
[PubMed PMID: 24711656]
[8]
Brouzas D,Koutsandrea C,Moschos M,Papadimitriou S,Ladas I,Apostolopoulos M, Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin) for AMD followed by controlateral sympathetic ophthalmia. Clinical ophthalmology (Auckland, N.Z.). 2009;
[PubMed PMID: 19714263]
[9]
Agarwal M,Radosavljevic A,Tyagi M,Pichi F,Al Dhanhani AA,Agarwal A,Cunningham ET Jr, Sympathetic Ophthalmia - An Overview. Ocular immunology and inflammation. 2022 May 17;
[PubMed PMID: 35579612]
Level 3 (low-level) evidence
[10]
He B,Tanya SM,Wang C,Kezouh A,Torun N,Ing E, The Incidence of Sympathetic Ophthalmia After Trauma: A Meta-analysis. American journal of ophthalmology. 2022 Feb;
[PubMed PMID: 34283983]
Level 1 (high-level) evidence
[11]
Tyagi M,Agarwal K,Reddy Pappuru RR,Dedhia C,Agarwal H,Nayak S,Panchal B,Kaza H,Basu S,Pathengay A,Murthy S,Sangwan VS, Sympathetic Ophthalmia after Vitreoretinal Surgeries: Incidence, Clinical Presentations and Outcomes of a Rare Disease. Seminars in ophthalmology. 2019;
[PubMed PMID: 31055985]
[12]
Hashimoto Y,Matsui H,Michihata N,Ishimaru M,Yasunaga H,Aihara M,Kaburaki T, Incidence of Sympathetic Ophthalmia after Inciting Events: A National Database Study in Japan. Ophthalmology. 2022 Mar;
[PubMed PMID: 34560127]
[13]
Galor A,Davis JL,Flynn HW Jr,Feuer WJ,Dubovy SR,Setlur V,Kesen MR,Goldstein DA,Tessler HH,Ganelis IB,Jabs DA,Thorne JE, Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye. American journal of ophthalmology. 2009 Nov;
[PubMed PMID: 19665105]
[14]
Gupta V,Gupta A,Dogra MR, Posterior sympathetic ophthalmia: a single centre long-term study of 40 patients from North India. Eye (London, England). 2008 Dec;
[PubMed PMID: 17618240]
[15]
Dutta Majumder P,Anthony E,George AE,Ganesh SK,Biswas J, Postsurgical sympathetic ophthalmia: retrospective analysis of a rare entity. International ophthalmology. 2018 Dec;
[PubMed PMID: 29164454]
Level 2 (mid-level) evidence
[16]
Abu El-Asrar AM,Struyf S,Van den Broeck C,Van Damme J,Opdenakker G,Geboes K,Kestelyn P, Expression of chemokines and gelatinase B in sympathetic ophthalmia. Eye (London, England). 2007 May;
[PubMed PMID: 16601741]
[18]
Tan XL,Seen S,Dutta Majumder P,Ganesh SK,Agarwal M,Soni A,Biswas J,Aggarwal K,Mahendradas P,Gupta V,Ling HS,Teoh S,Pavesio C,Agrawal R, Analysis of 130 Cases of Sympathetic Ophthalmia - A Retrospective Multicenter Case Series. Ocular immunology and inflammation. 2019;
[PubMed PMID: 30207811]
Level 2 (mid-level) evidence
[19]
Rao NA,Robin J,Hartmann D,Sweeney JA,Marak GE Jr, The role of the penetrating wound in the development of sympathetic ophthalmia experimental observations. Archives of ophthalmology (Chicago, Ill. : 1960). 1983 Jan;
[PubMed PMID: 6849641]
[20]
de Kozak Y,Sakai J,Thillaye B,Faure JP, S antigen-induced experimental autoimmune uveo-retinitis in rats. Current eye research. 1981;
[PubMed PMID: 6975701]
[21]
Schalken JJ,Winkens HJ,Van Vugt AH,De Grip WJ,Broekhuyse RM, Rhodopsin-induced experimental autoimmune uveoretinitis in monkeys. The British journal of ophthalmology. 1989 Mar;
[PubMed PMID: 2706205]
[22]
Gery I,Wiggert B,Redmond TM,Kuwabara T,Crawford MA,Vistica BP,Chader GJ, Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein. Investigative ophthalmology
[PubMed PMID: 3488297]
[23]
Gery I,Chanaud NP 3rd,Anglade E, Recoverin is highly uveitogenic in Lewis rats. Investigative ophthalmology
[PubMed PMID: 8045724]
[24]
Kilmartin DJ,Wilson D,Liversidge J,Dick AD,Bruce J,Acheson RW,Urbaniak SJ,Forrester JV, Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. The British journal of ophthalmology. 2001 Mar;
[PubMed PMID: 11222331]
[25]
Shindo Y,Ohno S,Usui M,Ideta H,Harada K,Masuda H,Inoko H, Immunogenetic study of sympathetic ophthalmia. Tissue antigens. 1997 Feb;
[PubMed PMID: 9062965]
[26]
Chen S,Aronow ME,Wang C,Shen D,Chan CC, Classical pathology of sympathetic ophthalmia presented in a unique case. The open ophthalmology journal. 2014;
[PubMed PMID: 25067979]
Level 3 (low-level) evidence
[27]
Shah DN,Piacentini MA,Burnier MN,McLean IW,Nussenblatt RB,Chan CC, Inflammatory cellular kinetics in sympathetic ophthalmia a study of 29 traumatized (exciting) eyes. Ocular immunology and inflammation. 1993;
[PubMed PMID: 22822781]
[28]
Aziz HA,Flynn HW Jr,Young RC,Davis JL,Dubovy SR, SYMPATHETIC OPHTHALMIA: Clinicopathologic Correlation in a Consecutive Case Series. Retina (Philadelphia, Pa.). 2015 Aug;
[PubMed PMID: 25719985]
Level 2 (mid-level) evidence
[29]
Balamurugan S,Das D,Hasanreisoglu M,Toy BC,Akhter M,Anuradha VK,Anthony E,Gurnani B,Kaur K, Interleukins and cytokine biomarkers in uveitis. Indian journal of ophthalmology. 2020 Sep;
[PubMed PMID: 32823391]
[30]
Croxatto JO,Rao NA,McLean IW,Marak GE, Atypical histopathologic features in sympathetic ophthalmia. A study of a hundred cases. International ophthalmology. 1982 Feb;
[PubMed PMID: 7068330]
Level 3 (low-level) evidence
[31]
Lubin JR,Albert DM,Weinstein M, Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of 105 cases (1913--1978). Ophthalmology. 1980 Feb;
[PubMed PMID: 7383540]
Level 3 (low-level) evidence
[32]
Reynard M,Riffenburgh RS,Minckler DS, Morphological variation of Dalén-Fuchs nodules in sympathetic ophthalmia. The British journal of ophthalmology. 1985 Mar;
[PubMed PMID: 3978066]
[33]
Chu XK,Chan CC, Sympathetic ophthalmia: to the twenty-first century and beyond. Journal of ophthalmic inflammation and infection. 2013 Jun 1;
[PubMed PMID: 23724856]
[34]
Parchand S,Agrawal D,Ayyadurai N,Agarwal A,Gangwe A,Behera S,Bhatia P,Mulkutkar S,Barwar G,Singh R,Sen A,Agarwal M, Sympathetic ophthalmia: A comprehensive update. Indian journal of ophthalmology. 2022 Jun;
[PubMed PMID: 35647958]
[35]
Paulbuddhe V,Addya S,Gurnani B,Singh D,Tripathy K,Chawla R, Sympathetic Ophthalmia: Where Do We Currently Stand on Treatment Strategies? Clinical ophthalmology (Auckland, N.Z.). 2021;
[PubMed PMID: 34707340]
[36]
Goto H,Rao NA, Sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome. International ophthalmology clinics. 1990 Fall;
[PubMed PMID: 2228475]
[37]
Keane PA,Sadda SR, Retinal imaging in the twenty-first century: state of the art and future directions. Ophthalmology. 2014 Dec;
[PubMed PMID: 25282252]
Level 3 (low-level) evidence
[38]
Fleischman D,Say EA,Wright JD,Landers MB, Multimodality diagnostic imaging in a case of sympathetic ophthalmia. Ocular immunology and inflammation. 2012 Aug;
[PubMed PMID: 22594960]
Level 3 (low-level) evidence
[39]
Mahajan S,Invernizzi A,Agrawal R,Biswas J,Rao NA,Gupta V, Multimodal Imaging in Sympathetic Ophthalmia. Ocular immunology and inflammation. 2017 Apr;
[PubMed PMID: 27960610]
[40]
Meleth AD,Sen HN, Use of fundus autofluorescence in the diagnosis and management of uveitis. International ophthalmology clinics. 2012 Fall;
[PubMed PMID: 22954928]
[41]
Agarwal A,Freund KB,Kumar A,Aggarwal K,Sharma D,Katoch D,Bansal R,Gupta V,OCTA Study Group, BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis. Retina (Philadelphia, Pa.). 2021 Apr 1;
[PubMed PMID: 32833410]
[42]
Muakkassa NW,Witkin AJ, Spectral-domain optical coherence tomography of sympathetic ophthalmia with Dalen-Fuchs nodules. Ophthalmic surgery, lasers
[PubMed PMID: 25347826]
[43]
Agrawal R,Jain M,Khan R,Jaisankar D,Xin W,Ding J,Testi I,Raman R,Biswas J, Choroidal Structural Changes in Sympathetic Ophthalmia on Swept-Source Optical Coherence Tomography. Ocular immunology and inflammation. 2021 Apr 3;
[PubMed PMID: 31743045]
[44]
Behdad B,Rahmani S,Montahaei T,Soheilian R,Soheilian M, Enhanced depth imaging OCT (EDI-OCT) findings in acute phase of sympathetic ophthalmia. International ophthalmology. 2015 Jun;
[PubMed PMID: 25772275]
[45]
Wilkins CS,Chen M,Chandra G,Muldoon TO,Sidoti PA,Samson CM,Rosen RB, "Persistence of Memory" - Multimodal imaging of delayed sympathetic ophthalmia. American journal of ophthalmology case reports. 2022 Sep;
[PubMed PMID: 35845745]
Level 3 (low-level) evidence
[46]
Brar M,Sharma M,Grewal SPS,Grewal DS, Treatment Response in Sympathetic Ophthalmia as Assessed by Widefield OCT Angiography. Ophthalmic surgery, lasers
[PubMed PMID: 30222810]
[47]
Levison AL,Baynes KM,Lowder CY,Kaiser PK,Srivastava SK, Choroidal neovascularisation on optical coherence tomography angiography in punctate inner choroidopathy and multifocal choroiditis. The British journal of ophthalmology. 2017 May;
[PubMed PMID: 27539089]
[49]
Sharp DC,Bell RA,Patterson E,Pinkerton RM, Sympathetic ophthalmia. Histopathologic and fluorescein angiographic correlation. Archives of ophthalmology (Chicago, Ill. : 1960). 1984 Feb;
[PubMed PMID: 6696668]
[50]
Wang RC,Zamir E,Dugel PU,Sipperley JO,Thirkill CE,Shabatian B,Rao NA, Progressive subretinal fibrosis and blindness associated with multifocal granulomatous chorioretinitis: A variant of sympathetic ophthalmia. Ophthalmology. 2002 Aug;
[PubMed PMID: 12153806]
[51]
Casella AM,Farah ME,Martins MC,Hasegawa A,Oguido AP, Sympathetic ophthalmia - histopathological correlation with fluorescein and indocyanine green angiography: case report. Arquivos brasileiros de oftalmologia. 2008 Nov-Dec;
[PubMed PMID: 19169528]
Level 3 (low-level) evidence
[52]
Saatci AO,Paşa E,Söylev MF,Koçak N,Durak I,Kaynak S, Sympathetic ophthalmia and indocyanine green angiography. Archives of ophthalmology (Chicago, Ill. : 1960). 2004 Oct;
[PubMed PMID: 15477482]
[53]
Moshfeghi AA,Harrison SA,Ferrone PJ, Indocyanine green angiography findings in sympathetic ophthalmia. Ophthalmic surgery, lasers
[PubMed PMID: 15792321]
[54]
Bilyk JR, Enucleation, evisceration, and sympathetic ophthalmia. Current opinion in ophthalmology. 2000 Oct;
[PubMed PMID: 11148706]
Level 3 (low-level) evidence
[55]
Jordan DR,J Dutton J, The Ruptured Globe, Sympathetic Ophthalmia, and the 14-Day Rule. Ophthalmic plastic and reconstructive surgery. 2022 Jul-Aug 01;
[PubMed PMID: 34593714]
[56]
Bellan L, Sympathetic ophthalmia: a case report and review of the need for prophylactic enucleation. Canadian journal of ophthalmology. Journal canadien d
[PubMed PMID: 10321321]
Level 3 (low-level) evidence
[57]
Brackup AB,Carter KD,Nerad JA,Folk JC,Pulido JS, Long-term follow-up of severely injured eyes following globe rupture. Ophthalmic plastic and reconstructive surgery. 1991;
[PubMed PMID: 1911526]
[58]
Savar A,Andreoli MT,Kloek CE,Andreoli CM, Enucleation for open globe injury. American journal of ophthalmology. 2009 Apr;
[PubMed PMID: 19181305]
[59]
Pieramici DJ, Sternberg P Jr, Aaberg TM Sr, Bridges WZ Jr, Capone A Jr, Cardillo JA, de Juan E Jr, Kuhn F, Meredith TA, Mieler WF, Olsen TW, Rubsamen P, Stout T. A system for classifying mechanical injuries of the eye (globe). The Ocular Trauma Classification Group. American journal of ophthalmology. 1997 Jun:123(6):820-31
[PubMed PMID: 9535627]
[60]
McBain HB,Ezra DG,Rose GE,Newman SP,Appearance Research Collaboration (ARC), The psychosocial impact of living with an ocular prosthesis. Orbit (Amsterdam, Netherlands). 2014 Feb;
[PubMed PMID: 24205995]
[61]
Green WR,Maumenee AE,Sanders TE,Smith ME, Sympathetic uveitis following evisceration. Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology. 1972 May-Jun;
[PubMed PMID: 4667676]
[62]
Chan CC,Roberge RG,Whitcup SM,Nussenblatt RB, 32 cases of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, Md., from 1982 to 1992. Archives of ophthalmology (Chicago, Ill. : 1960). 1995 May;
[PubMed PMID: 7748129]
Level 2 (mid-level) evidence
[63]
Chawla R,Kapoor M,Mehta A,Tripathy K,Vohra R,Venkatesh P, Sympathetic Ophthalmia: Experience from a Tertiary Care Center in Northern India. Journal of ophthalmic
[PubMed PMID: 30479714]
[64]
Gupta V,Gupta A,Dogra MR,Singh I, Reversible retinal changes in the acute stage of sympathetic ophthalmia seen on spectral domain optical coherence tomography. International ophthalmology. 2011 Apr;
[PubMed PMID: 21331811]
[65]
Arevalo JF,Garcia RA,Al-Dhibi HA,Sanchez JG,Suarez-Tata L, Update on sympathetic ophthalmia. Middle East African journal of ophthalmology. 2012 Jan;
[PubMed PMID: 22346110]
[66]
Meira J,Madeira C,Falcão-Reis F,Figueira L, Sustained Control from Recurring Non-Infectious Uveitic Macular Edema with 0.19 mg Fluocinolone Acetonide Intravitreal Implant - A Case Report. Ophthalmology and therapy. 2019 Dec;
[PubMed PMID: 31506865]
Level 3 (low-level) evidence
[67]
Wocker L,Januschowski K, [Steroid implant in treatment of sympathetic ophthalmia : Intravitreal implant of dexamethasone in cystoid macular edema in the context of sympathetic ophthalmia]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 2019 Apr;
[PubMed PMID: 29948149]
[68]
Mansour AM, Dexamethasone Implant as Sole Therapy in Sympathetic Ophthalmia. Case reports in ophthalmology. 2018 May-Aug;
[PubMed PMID: 29928220]
Level 3 (low-level) evidence
[69]
Kaçmaz RO,Kempen JH,Newcomb C,Daniel E,Gangaputra S,Nussenblatt RB,Rosenbaum JT,Suhler EB,Thorne JE,Jabs DA,Levy-Clarke GA,Foster CS, Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010 Mar;
[PubMed PMID: 20031223]
[70]
Wand K,Straub M,Lohmann CP,Mayer CS, [Sympathetic ophthalmia : Therapy with steroid-free immunosuppressant azathioprine]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 2016 Oct;
[PubMed PMID: 26879557]
[71]
Foster CS,Kothari S,Anesi SD,Vitale AT,Chu D,Metzinger JL,Cerón O, The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management. Survey of ophthalmology. 2016 Jan-Feb;
[PubMed PMID: 26164736]
Level 3 (low-level) evidence
[72]
Patel SS,Dodds EM,Echandi LV,Couto CA,Schlaen A,Tessler HH,Goldstein DA, Long-term, drug-free remission of sympathetic ophthalmia with high-dose, short-term chlorambucil therapy. Ophthalmology. 2014 Feb;
[PubMed PMID: 24572676]
[73]
Standardization of Uveitis Nomenclature (SUN) Working Group, Classification Criteria for Vogt-Koyanagi-Harada Disease. American journal of ophthalmology. 2021 Aug;
[PubMed PMID: 33845018]
[74]
Yang P,Liu S,Zhong Z,Du L,Ye Z,Zhou W,Kijlstra A, Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients. Ophthalmology. 2019 Sep;
[PubMed PMID: 30959067]
[76]
Huang X,Qin X,Luo Z,Li L,Hu J, Tuberculous choroiditis masquerading as sympathetic ophthalmia: a case report. Intractable
[PubMed PMID: 32844076]
Level 2 (mid-level) evidence
[77]
Rua D,Pohlmann D,Pleyer U, Sympathetic Ophthalmia - a Contribution to Immunology, Clinic and Current Imaging. Klinische Monatsblatter fur Augenheilkunde. 2020 Sep;
[PubMed PMID: 32967030]
[78]
Ganesh SK,Sundaram PM,Biswas J,Babu K, Cataract surgery in sympathetic ophthalmia. Journal of cataract and refractive surgery. 2004 Nov;
[PubMed PMID: 15519091]
[79]
Kalogeropoulos D,Sung VC, Pathogenesis of Uveitic Glaucoma. Journal of current glaucoma practice. 2018 Sep-Dec;
[PubMed PMID: 31354205]
[80]
Saatçi AO,Ayhan Z,İpek ŞC,Söylev Bajin M, Intravitreal Aflibercept as an Adjunct to Systemic Therapy in a Case of Choroidal Neovascular Membrane Associated with Sympathetic Ophthalmia. Turkish journal of ophthalmology. 2018 Aug;
[PubMed PMID: 30202619]
Level 3 (low-level) evidence